8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Apr 24, 2026·SEC
Material company update
Apr 3, 2026·SEC
GoodRx Holdings, Inc.(GDRX)Earnings, Financials & Key Ratios
GDRX•NASDAQ
$2.57
$881M mkt cap·30.1× P/E·Price updated May 6, 2026
AboutGoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.Show more
- Revenue$797M+0.6%
- EBITDA$192M+42.0%
- Net Income$30M+85.7%
- EPS (Diluted)0.09+104.1%
- Gross Margin82.09%-12.6%
- EBITDA Margin24.12%+41.2%
- Operating Margin13.42%+61.5%
- Net Margin3.82%+84.7%
- ROE4.54%+105.9%
- ROIC13.01%+113.4%
- Debt/Equity0.10-87.1%
- Interest Coverage2.33+45.9%
GDRX Key Insights
GoodRx Holdings, Inc. (GDRX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓FCF machine: 20.6% free cash flow margin
- ✓High quality earnings: Operating CF exceeds net income
- ✓Share count reduced 9.0% through buybacks
- ✓Trading at only 1.5x book value
✗Weaknesses
- ✗Weak 3Y average ROE of 1.9%
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
GDRX Price & Volume
GoodRx Holdings, Inc. (GDRX) stock price & volume — 10-year historical chart
Loading chart...
GDRX Growth Metrics
GoodRx Holdings, Inc. (GDRX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years7.67%
3 Years1.3%
TTM-1.19%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-19.73%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-16.63%
Return on Capital
10 Years6.35%
5 Years2.57%
3 Years3.95%
Last Year8.83%
GDRX Recent Earnings
GoodRx Holdings, Inc. (GDRX) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (17%)●Beat Revenue 7/12 qtrs (58%)
Q1 2026Latest
Feb 25, 2026EPS
$0.09
Est $0.09
+0.0%
Revenue
$195M
Est $193M
+0.8%
Q4 2025
Nov 4, 2025EPS
$0.08
Est $0.09
-11.1%
Revenue
$196M
Est $193M
+1.4%
Q3 2025
Aug 6, 2025EPS
$0.09
Est $0.10
-10.0%
Revenue
$203M
Est $205M
-1.1%
Q2 2025
May 7, 2025EPS
$0.09
Est $0.09
+0.0%
Revenue
$203M
Est $202M
+0.4%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 25, 2026 | $0.09vs $0.09+0.0% | $195Mvs $193M+0.8% |
| Q4 2025 | Nov 4, 2025 | $0.08vs $0.09-11.1% | $196Mvs $193M+1.4% |
| Q3 2025 | Aug 6, 2025 | $0.09vs $0.10-10.0% | $203Mvs $205M-1.1% |
| Q2 2025 | May 7, 2025 | $0.09vs $0.09+0.0% | $203Mvs $202M+0.4% |
Based on last 12 quarters of dataView full earnings history →
GDRX Peer Comparison
GoodRx Holdings, Inc. (GDRX) competitors in Patient Engagement, Intake and Payments — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HIMS | 6.94B | 26.88 | 52.71 | 59% | 5.47% | 23.73% | 2.07 | |
 TDOC | 1.23B | 6.80 | -5.96 | -1.54% | -6.81% | -12.37% | 0.75 | |
 OPRX | 120.61M | 6.47 | 23.96 | 18.78% | 4.69% | 4.22% | 0.04 | |
 PHVS | 1.96B | 30.11 | -10.35 | -53.18% | 0.00 | |||
 DOCS | 5.17B | 25.69 | 23.14 | 19.98% | 37.54% | 24.45% | 0.01 | |
 AMWL | 119.11M | 7.15 | -1.20 | -1.98% | -48.16% | -33.48% | 0.02 | |
 PGNY | 1.53B | 18.70 | 28.77 | 10.4% | 4.54% | 11.37% | 0.05 | |
 CVS | 111.32B | 86.86 | 62.49 | 7.85% | 0.72% | 3.86% | 1.24 |
Compare GDRX vs Peers
GoodRx Holdings, Inc. (GDRX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
GDRX Income Statement
GoodRx Holdings, Inc. (GDRX) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 249.52M | 388.22M | 550.7M | 745.42M | 766.55M | 750.26M | 792.32M | 796.85M | 787.89M |
| Revenue Growth % | - | 55.59% | 41.85% | 35.36% | 2.83% | -2.13% | 5.61% | 0.57% | -1.19% |
| Cost of Goods Sold | 6.04M | 14.02M | 29.59M | 46.72M | 65.08M | 66.92M | 48.22M | 142.72M | 149.51M |
| COGS % of Revenue | 2.42% | 3.61% | 5.37% | 6.27% | 8.49% | 8.92% | 6.09% | 17.91% | - |
| Gross Profit | 243.49M▲ 0% | 374.21M▲ 53.7% | 521.11M▲ 39.3% | 698.71M▲ 34.1% | 701.48M▲ 0.4% | 683.34M▼ 2.6% | 744.11M▲ 8.9% | 654.13M▼ 12.1% | 638.38M▲ 0% |
| Gross Margin % | 97.58% | 96.39% | 94.63% | 93.73% | 91.51% | 91.08% | 93.91% | 82.09% | 81.02% |
| Gross Profit Growth % | - | 53.69% | 39.26% | 34.08% | 0.4% | -2.59% | 8.89% | -12.09% | - |
| Operating Expenses | 166.24M | 234.53M | 796.83M | 685.3M | 699.74M | 710.35M | 678.26M | 547.16M | 540.78M |
| OpEx % of Revenue | 66.62% | 60.41% | 144.69% | 91.93% | 91.28% | 94.68% | 85.6% | 68.67% | - |
| Selling, General & Admin | 112.54M | 191.66M | 716.59M | 524.9M | 502.42M | 466.84M | 484.98M | 445.52M | 439.22M |
| SG&A % of Revenue | 45.1% | 49.37% | 130.12% | 70.42% | 65.54% | 62.22% | 61.21% | 55.91% | - |
| Research & Development | 43.89M | 29.3M | 61.82M | 125.86M | 143.14M | 135.84M | 123.75M | 121.03M | 120.06M |
| R&D % of Revenue | 17.59% | 7.55% | 11.22% | 16.88% | 18.67% | 18.11% | 15.62% | 15.19% | - |
| Other Operating Expenses | -7K | 13.57M | 18.43M | 34.54M | 54.18M | 107.67M | 69.54M | -19.39M | 99K |
| Operating Income | 77.25M▲ 0% | 139.68M▲ 80.8% | -275.72M▼ 297.4% | 13.41M▲ 104.9% | 1.74M▼ 87.0% | -27.01M▼ 1653.9% | 65.85M▲ 343.8% | 106.97M▲ 62.5% | 97.6M▲ 0% |
| Operating Margin % | 30.96% | 35.98% | -50.07% | 1.8% | 0.23% | -3.6% | 8.31% | 13.42% | 12.39% |
| Operating Income Growth % | - | 80.81% | -297.4% | 104.86% | -87.04% | -1653.91% | 343.81% | 62.46% | - |
| EBITDA | 87.06M | 153.25M | -257.29M | 47.95M | 55.91M | 80.66M | 135.38M | 192.19M | 183.7M |
| EBITDA Margin % | 34.89% | 39.47% | -46.72% | 6.43% | 7.29% | 10.75% | 17.09% | 24.12% | 23.32% |
| EBITDA Growth % | - | 76.03% | -267.89% | 118.63% | 16.62% | 44.26% | 67.84% | 41.96% | 17.49% |
| D&A (Non-Cash Add-back) | 9.81M | 13.57M | 18.43M | 34.54M | 54.18M | 107.67M | 69.54M | 85.22M | 86.1M |
| EBIT | 74.54M | 132.55M | -275.54M | 13.46M | 11.01M | 1.16M | 84.38M | 99.14M | 71.83M |
| Net Interest Income | -22.04M | -48.85M | -27.75M | -23.58M | -24.97M | -24.56M | -29.65M | -31.67M | -24.96M |
| Interest Income | 154K | 715K | 160K | 59K | 9.27M | 32.17M | 23.27M | 10.93M | 6.09M |
| Interest Expense | 22.19M | 49.57M | 27.91M | 23.64M | 34.24M | 56.73M | 52.92M | 42.6M | 19.89M |
| Other Income/Expense | -24.9M | -56.7M | -27.73M | -23.58M | -24.97M | -28.57M | -34.39M | -50.43M | -52.09M |
| Pretax Income | 52.35M▲ 0% | 82.98M▲ 58.5% | -303.45M▼ 465.7% | -10.18M▲ 96.6% | -23.23M▼ 128.3% | -55.57M▼ 139.2% | 31.46M▲ 156.6% | 56.54M▲ 79.7% | 45.51M▲ 0% |
| Pretax Margin % | 20.98% | 21.37% | -55.1% | -1.37% | -3.03% | -7.41% | 3.97% | 7.1% | 5.78% |
| Income Tax | 8.55M | 16.93M | -9.83M | 15.08M | 9.6M | -46.7M | 15.07M | -26.1M | 16.01M |
| Effective Tax Rate % | 16.34% | 20.4% | 3.24% | -148.15% | -41.31% | 84.04% | 47.9% | -46.16% | 35.19% |
| Net Income | 43.79M▲ 0% | 66.05M▲ 50.8% | -293.62M▼ 544.6% | -25.25M▲ 91.4% | -32.83M▼ 30.0% | -8.87M▲ 73.0% | 16.39M▲ 284.8% | 30.44M▲ 85.7% | 29.5M▲ 0% |
| Net Margin % | 17.55% | 17.01% | -53.32% | -3.39% | -4.28% | -1.18% | 2.07% | 3.82% | 3.74% |
| Net Income Growth % | - | 50.82% | -544.56% | 91.4% | -29.99% | 72.99% | 284.82% | 85.72% | -19.73% |
| Net Income (Continuing) | 43.79M | 66.05M | -293.62M | -25.25M | -32.83M | -8.87M | 16.39M | 30.44M | 29.5M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.12▲ 0% | 0.12▲ 0.0% | -1.07▼ 991.7% | -0.06▲ 94.4% | -0.08▼ 33.3% | -0.02▲ 73.0% | 0.04▲ 293.5% | 0.09▲ 104.1% | 0.09▲ 0% |
| EPS Growth % | - | 0% | -991.67% | 94.39% | -33.33% | 73% | 293.52% | 104.07% | -16.63% |
| EPS (Basic) | 0.12 | 0.12 | -1.07 | -0.06 | -0.08 | -0.02 | 0.04 | 0.09 | - |
| Diluted Shares Outstanding | 362.6M | 362.6M | 274.7M | 409.98M | 412.86M | 410.31M | 392.17M | 356.97M | 341.42M |
| Basic Shares Outstanding | 356.07M | 356.07M | 274.7M | 409.98M | 412.86M | 410.31M | 385.74M | 356.33M | 340.53M |
| Dividend Payout Ratio | 3074.36% | - | - | - | - | - | - | - | - |
GDRX Balance Sheet
GoodRx Holdings, Inc. (GDRX) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 73.07M | 86.58M | 1.09B | 1.09B | 919.69M | 872.79M | 659.25M | 643.1M | 1.27B |
| Cash & Short-Term Investments | 34.6M | 26.05M | 971.59M | 941.11M | 757.16M | 672.3M | 448.35M | 261.82M | 235.71M |
| Cash Only | 34.6M | 26.05M | 971.59M | 941.11M | 757.16M | 672.3M | 448.35M | 261.82M | 235.71M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 33.36M | 55.52M | 97.29M | 126.41M | 121.67M | 160.04M | 160.83M | 235.75M | 232.72M |
| Days Sales Outstanding | 48.8 | 52.2 | 64.49 | 61.9 | 57.93 | 77.86 | 74.09 | 107.98 | 102.81 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.66M | 0 | 0 | 21.31M | 35.1M | 15.48M | 50.08M | 145.54M | 798.04M |
| Total Non-Current Assets | 241.72M | 300.21M | 408.22M | 518.8M | 684.95M | 716.01M | 728.81M | 760.96M | 754.78M |
| Property, Plant & Equipment | 988K | 34.17M | 50.77M | 49.32M | 55.73M | 45.86M | 40.46M | 41.08M | 40.49M |
| Fixed Asset Turnover | 252.55x | 11.36x | 10.85x | 15.11x | 13.76x | 16.36x | 19.58x | 19.40x | 19.22x |
| Goodwill | 220.42M | 236.22M | 261.12M | 329.7M | 412.12M | 410.77M | 410.77M | 430.33M | 430.33M |
| Intangible Assets | 18.27M | 26.45M | 56.72M | 133.78M | 189.94M | 156.34M | 176.88M | 64.08M | 61.17M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 15M | 15M | 0 | 0 |
| Other Non-Current Assets | 1.18M | 1.16M | 2.02M | 6.01M | 27.16M | 22.77M | 8.52M | 168.36M | 385.34M |
| Total Assets | 314.79M▲ 0% | 386.8M▲ 22.9% | 1.49B▲ 286.4% | 1.61B▲ 7.6% | 1.6B▼ 0.2% | 1.59B▼ 1.0% | 1.39B▼ 12.6% | 1.4B▲ 1.2% | 2.02B▲ 0% |
| Asset Turnover | 0.79x | 1.00x | 0.37x | 0.46x | 0.48x | 0.47x | 0.57x | 0.57x | 0.52x |
| Asset Growth % | - | 22.87% | 286.4% | 7.56% | -0.19% | -0.99% | -12.63% | 1.15% | 44.42% |
| Total Current Liabilities | 16.62M | 33.37M | 59.55M | 81.11M | 76.32M | 122.56M | 123.9M | 246M | 859.2M |
| Accounts Payable | 7.2M | 7.85M | 10.29M | 17.5M | 17.7M | 36.27M | 14.14M | 19.41M | 14.53M |
| Days Payables Outstanding | 435.46 | 204.45 | 126.95 | 136.74 | 99.27 | 197.79 | 107.02 | 49.63 | 53.75 |
| Short-Term Debt | 5.43M | 7.03M | 11.57M | 7.03M | 7.03M | 8.79M | 5M | 9.75M | 9.98M |
| Deferred Revenue (Current) | 258K | 3.45M | 6.85M | 6.87M | 7.88M | 7.11M | 0 | 0 | 12.36M |
| Other Current Liabilities | 2.54M | 0 | 17.23M | 0 | 0 | 33.82M | 69.41M | 216.84M | 849.22M |
| Current Ratio | 4.40x | 2.59x | 18.24x | 13.42x | 12.05x | 7.12x | 5.32x | 2.61x | 2.61x |
| Quick Ratio | 4.40x | 2.59x | 18.24x | 13.42x | 12.05x | 7.12x | 5.32x | 2.61x | 2.61x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | 49.06 |
| Total Non-Current Liabilities | 1.46B | 1.44B | 723.68M | 694.83M | 713.48M | 704.28M | 539.51M | 541.79M | 540.07M |
| Long-Term Debt | 716.81M | 663.89M | 659.89M | 655.86M | 651.8M | 647.7M | 486.71M | 49.79M | 48.95M |
| Capital Lease Obligations | -737.01M | 37.13M | 33.47M | 33.59M | 54.13M | 48.4M | 46.04M | 0 | 104M |
| Deferred Tax Liabilities | 3.46M | 0 | 24.48M | 244K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -733.68M | 739.98M | 5.85M | 5.14M | 7.56M | 8.18M | 6.75M | 492M | 997.73M |
| Total Liabilities | 1.48B | 1.47B | 783.23M | 775.95M | 789.8M | 826.84M | 663.41M | 787.8M | 1.4B |
| Total Debt | 722.24M | 710.99M | 704.92M | 702.33M | 717.02M | 711.07M | 543.39M | 59.54M | 58.93M |
| Net Debt | 687.64M | 684.94M | -266.67M | -238.78M | -40.14M | 38.77M | 95.04M | -202.28M | -176.78M |
| Debt / Equity | - | - | 0.99x | 0.84x | 0.88x | 0.93x | 0.75x | 0.10x | 0.10x |
| Debt / EBITDA | 8.30x | 4.64x | - | 14.65x | 12.82x | 8.82x | 4.01x | 0.31x | 0.32x |
| Net Debt / EBITDA | 7.90x | 4.47x | - | -4.98x | -0.72x | 0.48x | 0.70x | -1.05x | -1.05x |
| Interest Coverage | 3.36x | 2.67x | -9.87x | 0.57x | 0.32x | 0.02x | 1.59x | 2.33x | 3.61x |
| Total Equity | -1.16B▲ 0% | -1.09B▲ 6.4% | 711.36M▲ 165.4% | 831.68M▲ 16.9% | 814.83M▼ 2.0% | 761.96M▼ 6.5% | 724.66M▼ 4.9% | 616.26M▼ 15.0% | 621.99M▲ 0% |
| Equity Growth % | - | 6.44% | 165.41% | 16.91% | -2.03% | -6.49% | -4.9% | -14.96% | -37.59% |
| Book Value per Share | -3.21 | -3.00 | 2.59 | 2.03 | 1.97 | 1.86 | 1.85 | 1.73 | 1.82 |
| Total Shareholders' Equity | -1.16B | -1.09B | 711.36M | 831.68M | 814.83M | 761.96M | 724.66M | 616.26M | 621.99M |
| Common Stock | 451K | 460K | 39K | 40K | 40K | 40K | 38K | 34K | 34K |
| Retained Earnings | -1.16B | -1.1B | -1.39B | -1.42B | -1.45B | -1.46B | -1.44B | -1.41B | -1.41B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -554K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GDRX Cash Flow Statement
GoodRx Holdings, Inc. (GDRX) cash flow — operating, investing & free cash flow history
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 45.25M | 83.29M | 131.34M | 178.78M | 146.78M | 138.29M | 183.89M | 167.9M | 167.9M |
| Operating CF Margin % | 18.14% | 21.45% | 23.85% | 23.98% | 19.15% | 18.43% | 23.21% | 21.07% | - |
| Operating CF Growth % | - | 84.05% | 57.7% | 36.12% | -17.9% | -5.78% | 32.97% | -8.69% | 397.87% |
| Net Income | 43.79M | 66.05M | -293.62M | -25.25M | -32.83M | -8.87M | 16.39M | 25.01M | 29.5M |
| Depreciation & Amortization | 9.81M | 13.57M | 18.43M | 34.54M | 54.18M | 111.77M | 69.54M | 81.68M | 82.56M |
| Stock-Based Compensation | 1.76M | 3.75M | 397.29M | 160.46M | 120.23M | 104.82M | 99.03M | 58.66M | 55.99M |
| Deferred Taxes | -2.43M | -5.67M | -10.91M | 12.85M | -497K | -65.56M | -11.91M | 0 | 4.07M |
| Other Non-Cash Items | 4.1M | 10.41M | 52.62M | 7.98M | 25.98M | 18.07M | 8.76M | 59M | 21.09M |
| Working Capital Changes | -11.77M | -4.82M | -32.46M | -11.8M | -20.29M | -21.94M | 2.09M | -56.44M | -8.51M |
| Change in Receivables | -12.84M | -14.52M | -16.14M | -43.95M | 1.38M | -26.47M | -2.33M | -88.02M | -70.81M |
| Change in Inventory | -2.55M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 665K | 515K | 2.15M | 4.21M | -874K | 17.46M | -21.24M | 4.1M | -1.13M |
| Cash from Investing | -3.46M | -37.05M | -91.62M | -178.73M | -210.5M | -55.77M | -70.35M | -119.96M | -89.73M |
| Capital Expenditures | -3.46M | -1.43M | -20.55M | -4.57M | -3.97M | -1.04M | 0 | -2.28M | -19.1M |
| CapEx % of Revenue | 1.39% | 0.37% | 3.73% | 0.61% | 0.52% | 0.14% | 8.88% | 0.29% | - |
| Acquisitions | 0 | -31.31M | -55.79M | -144.28M | -155.28M | 0 | 0 | -30M | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | -2.65M | -4.32M | -15.27M | -29.89M | -51.25M | -54.72M | -70.35M | -87.68M | -70.62M |
| Cash from Financing | -24.73M | -54.78M | 905.82M | -30.53M | -120.23M | -167.4M | -337.5M | -234.47M | -145.87M |
| Debt Issued (Net) | 606.88M | -57.23M | -7.03M | -7.03M | -7.03M | -5.27M | -167M | -3.75M | -3.75M |
| Equity Issued (Net) | 0 | 1.62M | 991.79M | 0 | -101.72M | -103.97M | -158.84M | -206.94M | -117.33M |
| Dividends Paid | -1.35B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | -101.72M | -103.97M | -158.84M | -206.94M | -129.04M |
| Other Financing | 714.75M | 828K | -78.95M | -23.5M | -11.48M | -58.15M | -11.64M | -23.78M | -24.79M |
| Net Change in Cash | 17.06M▲ 0% | -8.55M▼ 150.1% | 945.54M▲ 11159.0% | -30.48M▼ 103.2% | -183.94M▼ 503.5% | -84.87M▲ 53.9% | -223.95M▼ 163.9% | -186.53M▲ 16.7% | -39.16M▲ 0% |
| Free Cash Flow | 41.8M▲ 0% | 77.54M▲ 85.5% | 95.52M▲ 23.2% | 144.32M▲ 51.1% | 91.57M▼ 36.6% | 82.53M▼ 9.9% | 113.55M▲ 37.6% | 164.38M▲ 44.8% | 131.64M▲ 0% |
| FCF Margin % | 16.75% | 19.97% | 17.34% | 19.36% | 11.95% | 11% | 14.33% | 20.63% | 16.71% |
| FCF Growth % | - | 85.52% | 23.19% | 51.1% | -36.55% | -9.87% | 37.59% | 44.77% | 39.2% |
| FCF per Share | 0.12 | 0.21 | 0.35 | 0.35 | 0.22 | 0.20 | 0.29 | 0.46 | 0.46 |
| FCF Conversion (FCF/Net Income) | 1.03x | 1.26x | -0.45x | -7.08x | -4.47x | -15.59x | 11.22x | 5.52x | 4.46x |
| Interest Paid | 18.66M | 48.44M | 24.52M | 20.2M | 30.7M | 48.8M | 55.1M | 40.84M | 0 |
| Taxes Paid | 11.7M | 19.4M | 29.23M | 18.11M | 4.36M | 17.24M | 23.62M | 13.13M | 0 |
GDRX Key Ratios
GoodRx Holdings, Inc. (GDRX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -41.28% | -3.27% | -3.99% | -1.12% | 2.21% | 4.54% | 4.75% |
| Return on Invested Capital (ROIC) | - | -983.61% | 1.94% | 0.19% | -2.57% | 6.1% | 13.01% | 13.01% |
| Gross Margin | 96.39% | 94.63% | 93.73% | 91.51% | 91.08% | 93.91% | 82.09% | 81.02% |
| Net Margin | 17.01% | -53.32% | -3.39% | -4.28% | -1.18% | 2.07% | 3.82% | 3.74% |
| Debt / Equity | - | 0.99x | 0.84x | 0.88x | 0.93x | 0.75x | 0.10x | 0.10x |
| Interest Coverage | 2.67x | -9.87x | 0.57x | 0.32x | 0.02x | 1.59x | 2.33x | 3.61x |
| FCF Conversion | 1.26x | -0.45x | -7.08x | -4.47x | -15.59x | 11.22x | 5.52x | 4.46x |
| Revenue Growth | 55.59% | 41.85% | 35.36% | 2.83% | -2.13% | 5.61% | 0.57% | -1.19% |
GDRX SEC Filings & Documents
GoodRx Holdings, Inc. (GDRX) SEC filings — annual & quarterly reports (10-K, 10-Q)
GDRX Frequently Asked Questions
GoodRx Holdings, Inc. (GDRX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
GoodRx Holdings, Inc. (GDRX) reported $787.9M in revenue for fiscal year 2025. This represents a 216% increase from $249.5M in 2018.
GoodRx Holdings, Inc. (GDRX) grew revenue by 0.6% over the past year. Growth has been modest.
Yes, GoodRx Holdings, Inc. (GDRX) is profitable, generating $29.5M in net income for fiscal year 2025 (3.8% net margin).
Dividend & Returns
GoodRx Holdings, Inc. (GDRX) has a return on equity (ROE) of 4.5%. This is below average, suggesting room for improvement.
GoodRx Holdings, Inc. (GDRX) generated $131.6M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More GDRX
GoodRx Holdings, Inc. (GDRX) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates